Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Wiki lists this spending on average in R&D per app

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154090
(Total Views: 528)
Posted On: 08/20/2019 5:53:21 PM
Avatar
Posted By: trding
Re: trding #6392
Wiki lists this spending on average in R&D per approved drug from an article written by Pfizer Japan, I'm attempting to track down the article to verify.

422380186_costperdrug.jpg

Another one, this one available also to compare, total cost/number of approved drugs
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847363/
1684537725_cost2.jpg


Phase 3 costs on average, looking for breakout of US, which I am guessing will be on the high end given the second paragraph:

https://www.nature.com/articles/d41591-019-00008-7
Quote:
Costs are particularly high for late-stage clinical trials, which often involve large cohorts of patients. According to Gen Li, president of Phesi—a company that claims to have the “industry’s most comprehensive and dynamic clinical trials database”— analysis of a sample of 4,363 phase 3 trials revealed an average cost of “around $30 million to implement” each.

The location of a trial also impacts its cost2. For example, in China or India, a clinical trial can be conducted for a cost that is 30–40% lower than it would be in the United States—for various reasons, including lower prices of testing procedures, such as an electrocardiogram. But the outsourcing of clinical trials to other countries is not without controversy.







(0)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us